| 000 | 01701 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516204211.0 | ||
| 264 | 0 | _c20150413 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1592-8721 | ||
| 024 | 7 |
_a10.3324/haematol.2013.101261 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCompagno, Nicolò | |
| 245 | 0 | 0 |
_aSubcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients. _h[electronic resource] |
| 260 |
_bHaematologica _cJun 2014 |
||
| 300 |
_a1101-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAgammaglobulinemia _xdrug therapy |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadverse effects |
| 650 | 0 | 4 | _aDrug Substitution |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 |
_aImmunoglobulins _xadministration & dosage |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xadministration & dosage |
| 650 | 0 | 4 |
_aImmunologic Factors _xadverse effects |
| 650 | 0 | 4 |
_aInfections _xetiology |
| 650 | 0 | 4 | _aInfusions, Subcutaneous |
| 650 | 0 | 4 |
_aLymphoproliferative Disorders _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aCinetto, Francesco | |
| 700 | 1 | _aSemenzato, Gianpietro | |
| 700 | 1 | _aAgostini, Carlo | |
| 773 | 0 |
_tHaematologica _gvol. 99 _gno. 6 _gp. 1101-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3324/haematol.2013.101261 _zAvailable from publisher's website |
| 999 |
_c23689581 _d23689581 |
||